Zai Lab

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. 

CEO
Ying Du
CEOYing Du
Employees
1,784
Employees1,784
Headquarters
Shanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded
2014
Founded2014
Employees
1,784
Employees1,784

ZLAB Key Statistics

Market cap
2.08B
Market cap2.08B
Price-Earnings ratio
-11.22
Price-Earnings ratio-11.22
Dividend yield
Dividend yield
Average volume
1.06M
Average volume1.06M
High today
$19.08
High today$19.08
Low today
$17.99
Low today$17.99
Open price
$18.40
Open price$18.40
Volume
978.12K
Volume978.12K
52 Week high
$41.20
52 Week high$41.20
52 Week low
$15.96
52 Week low$15.96

ZLAB News

Simply Wall St 1d
Why Zai Lab Is Up 6.5% After Dual TIVDAK China Approval and EU Orphan Win – And What's Next

Zai Lab has recently gained China NMPA approval for TIVDAK in recurrent or metastatic cervical cancer and secured European Orphan Drug Designation for zocilurta...

Why Zai Lab Is Up 6.5% After Dual TIVDAK China Approval and EU Orphan Win – And What's Next
TipRanks 4d
Zai Lab Shareholders Approve Directors, Auditors and Mandates

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Simply Wall St 5d
Zai Lab Stock Could Be 47.5% Undervalued After China Approved TIVDAK - simplywall.st

...

Zai Lab Stock Could Be 47.5% Undervalued After China Approved TIVDAK - simplywall.st

Analyst ratings

86%

of 14 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More ZLAB News

TipRanks 5d
Zai Lab announces EMA granted ODD to zocilurtatug pelitecan

Zai Lab (ZLAB) announced the European Medicines Agency, EMA, has granted Orphan Drug Designation, ODD, to zocilurtatug pelitecan, the Company’s potential first-...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.